Skip to content

Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells

Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00442143
Acronym
DANCELL-CLI
Enrollment
10
Registered
2007-03-01
Start date
2007-01-31
Completion date
2007-12-31
Last updated
2010-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia

Keywords

CLI, PAOD, Severe lower limb ischemia

Brief summary

The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization

Detailed description

10 patients with severe lower limb ischemia will be included in this pilote trial. Bonemarrow aspiration will be performed and and the monocuclear cells isolated an injected into the gastrocnemius. The patiens are followed for 4 months. Were trancutaneous oxygenpressure, ankel and toe blood pressure is measured.

Interventions

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Ankle blood pressure \< 70 mmgHG * Either pain at rest and/or ischemic wound * No possible surgical treatment

Exclusion criteria

* Infection * Malignant disease

Design outcomes

Primary

MeasureTime frame
1st toe blood pressure (strain gauge)
Wound healing
Pain
Transcutaneous oxygen pressure
Ankle blood pressure

Secondary

MeasureTime frame
Infection
amputation

Countries

Denmark

Contacts

Primary ContactMalthe AM Kristiansen, MD
mkristiansen@health.sdu.dk+4565504081

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026